Figure 2 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size

Q: What type of study is this?

This is a In Vitro Study study (also classified as: Animal Study, Observational).

Jun Li; Zoe Welham; Benita Tse; Chahaya Gauci; Shila Ghazanfar; Pratibha Panwar; Alexander Engel; Mark P. Molloy

doi:10.1158/2767-9764.29939608

August 19, 2025Open Access

Figure 2 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size

View Full Paper

Ask AI

Bookmark

Share

Key Points

A distinct subgroup of low-grade bowel polyps shows concurrent high-risk oncogenic drivers, emphasizing identification importance.
Tumor mutation burden analysis highlights specific alterations in WNT pathway and associated oncogenic mutations.
Observational approach analyzes data from various types of bowel polyps, including TAs, TVAs, HPs, and SSLs.
Identifying high-risk mutations in low-grade polyps may shape surveillance strategies and preventive measures.

Implication

Analysis reveals oncogenic drivers in low-grade bowel polyps, indicating a subgroup at high risk for malignancy.

Abstract

Oncoplots of bowel polyps. A, WNT pathway alterations in TAs. B, Oncogenic mutations of eight WNT-independent TAs. C, Oncogenic mutations in eight TVAs. D, Oncogenic mutations in HPs. E, Oncogenic mutations in SSLs. TMB, tumor MB.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/68af454cad7bf08b1ead3486 https://doi.org/10.1158/2767-9764.29939608

View Full Paper

Ask AI

Bookmark

Share

Figure 2 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size

Key Points

Implication

Abstract

Discussion

Cite This Study

Figure 2 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading